Overview of Comments Received on ICH Q3E Guideline

# Executive Summary This whitepaper provides an overview of comments received on the ICH Q3E Guideline concerning extractables and leachables (E&L). Key findings include: - **Regulatory Insights**: Comments highlight the need for clarity on the application of E&L testing across various product types. - **Methodological Recommendations**: Suggestions for improving methodologies for assessing leachables and extractables in drug packaging. - **Terminology Consistency**: Calls for harmonization of terminology related to E&L to avoid confusion in regulatory contexts. - **Safety Assessments**: Emphasis on the importance of safety assessments for pediatric products and other vulnerable populations. - **Risk Assessment Protocols**: Recommendations for implementing risk-based approaches to determine the necessity of E&L testing.